Celebrex Linked To Increased Heart Attack Risk

Law360, New York (April 2, 2008, 12:00 AM EDT) -- A recent study has revealed that large doses of Pfizer Inc.’s pain medication Celebrex may increase the risk of cardiovascular events in patients, cautioning doctors against prescribing high doses of the drug to patients with a history of such events.

The study, sponsored by the National Cancer Institute and presented Monday at the American College of Cardiology’s annual meeting, found that patients taking a 400-mg dose of Celebrex twice daily had three times the risk of cardiovascular events, such as heart attack or stroke, compared to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.